Skip to content

Aptalis Pharma Inc

company.status.inactive

CIK 1444570fmd_0HHTT6GQJFRW7RS7PWWTZ36H9PManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Oct 01, 2008 to Dec 31, 2011, 7 periods

Latest annual · FY2011

Millions
Total revenues
470
Operating income
(66)
Net income
(188)
Free cash flow
(56)

Latest quarter · Q1 FY2012

Millions
Total revenues
152
Operating income
41
Net income
20
Free cash flow
9
Open Financials

Aptalis Pharma Inc financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011FY2010ChangeSource
Revenue$470.4 million$354.6 million+32.7%10-K 2011-12-20 · proof
Operating income-$66.4 million-$103.6 million10-K 2011-12-20 · proof
Net income-$187.9 million-$170.4 million10-K 2011-12-20 · proof
Cash from operating activities-$49 million$63.1 million-177.6%10-K 2011-12-20 · proof
Free cash flow-$56.4 million$57.1 million-198.9%10-K 2011-12-20 · proof
Total assets$1.3 billion$713.2 million+76.4%10-K 2011-12-20 · proof
Total liabilities$1.3 billion$734.2 million+75.1%10-K 2011-12-20 · proof
Cash and cash equivalents$126.5 million$161.5 million-21.7%10-K 2011-12-20 · proof
Total debt$976.9 million$594.5 million+64.3%10-K 2011-12-20 · proof
What was Aptalis Pharma Inc's revenue in fiscal 2011?
Aptalis Pharma Inc reported revenue of $470.4 million for fiscal 2011 (the year ended Sep 30, 2011), against $354.6 million the year before (+32.7%). Source: the 10-K filed with the SEC on Dec 20, 2011. SEC
What was Aptalis Pharma Inc's operating income in fiscal 2011?
Aptalis Pharma Inc reported operating income of -$66.4 million for fiscal 2011 (the year ended Sep 30, 2011), against -$103.6 million the year before. Source: the 10-K filed with the SEC on Dec 20, 2011. SEC
What was Aptalis Pharma Inc's net income in fiscal 2011?
Aptalis Pharma Inc reported net income of -$187.9 million for fiscal 2011 (the year ended Sep 30, 2011), against -$170.4 million the year before. Source: the 10-K filed with the SEC on Dec 20, 2011. SEC
What was Aptalis Pharma Inc's cash from operating activities in fiscal 2011?
Aptalis Pharma Inc reported cash from operating activities of -$49 million for fiscal 2011 (the year ended Sep 30, 2011), against $63.1 million the year before (-177.6%). Source: the 10-K filed with the SEC on Dec 20, 2011. SEC
What was Aptalis Pharma Inc's free cash flow in fiscal 2011?
Aptalis Pharma Inc reported free cash flow of -$56.4 million for fiscal 2011 (the year ended Sep 30, 2011), against $57.1 million the year before (-198.9%). Source: the 10-K filed with the SEC on Dec 20, 2011. SEC
What are Aptalis Pharma Inc's total assets?
As of Sep 30, 2011, Aptalis Pharma Inc reported total assets of $1.3 billion, against $713.2 million a year earlier (+76.4%). Source: the 10-K filed with the SEC on Dec 20, 2011. SEC
What are Aptalis Pharma Inc's total liabilities?
As of Sep 30, 2011, Aptalis Pharma Inc reported total liabilities of $1.3 billion, against $734.2 million a year earlier (+75.1%). Source: the 10-K filed with the SEC on Dec 20, 2011. SEC
What are Aptalis Pharma Inc's cash and cash equivalents?
As of Sep 30, 2011, Aptalis Pharma Inc reported cash and cash equivalents of $126.5 million, against $161.5 million a year earlier (-21.7%). Source: the 10-K filed with the SEC on Dec 20, 2011. SEC
What is Aptalis Pharma Inc's total debt?
As of Sep 30, 2011, Aptalis Pharma Inc reported total debt of $976.9 million, against $594.5 million a year earlier (+64.3%). Source: the 10-K filed with the SEC on Dec 20, 2011. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1444570&period_type=annual&limit=5"

Information only, not investment advice.